Institute of Oncology Ljubljana
Ljubljana, Slovenia
21 recruiting
Showing 1–20 of 20 trials
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Hoffmann-La Roche1,050 enrolled351 locationsNCT06065748
Recruiting
Phase 2
Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study)
Colorectal, CancerColon CancerPerioperative Immune Response
Institute of Oncology Ljubljana100 enrolled1 locationNCT07432399
Recruiting
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
HER2-negative Breast CancerEarly Breast CancerHormone Receptor Positive Tumor
Institute of Oncology Ljubljana319 enrolled1 locationNCT06650423
Recruiting
Phase 2
Electrochemotherapy for Recurrent Vulvar Cancer
Vulvar CancerRecurrent Vulvar Cancer
Institute of Oncology Ljubljana13 enrolled1 locationNCT07443475
Recruiting
Not Applicable
Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma
Diffuse Large B Cell Lymphoma
Institute of Oncology Ljubljana3 enrolled1 locationNCT07443514
Recruiting
Not Applicable
Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients
Breast CancerGynecologic CancerUrologic Cancer
Institute of Oncology Ljubljana30 enrolled1 locationNCT07416630
Recruiting
Not Applicable
Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
MelanomaSKIN NEOPLASMS
Institute of Oncology Ljubljana150 enrolled1 locationNCT07404605
Recruiting
Not Applicable
Quality Of Life In Colorectal Cancer Survivors
Colorectal, CancerColon CancerRectal Cancer
Institute of Oncology Ljubljana368 enrolled1 locationNCT07427901
Recruiting
Phase 3
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Uveal Melanoma
IDEAYA Biosciences520 enrolled87 locationsNCT07015190
Recruiting
Not Applicable
Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia
Metastatic MelanomaSkin Cancer
Institute of Oncology Ljubljana100 enrolled1 locationNCT07422779
Recruiting
Not Applicable
Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)
Locally Advanced Pancreatic Cancer
Institute of Oncology Ljubljana18 enrolled1 locationNCT07407231
Recruiting
Not Applicable
Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
MelanomaMetastatic Melanoma
Institute of Oncology Ljubljana40 enrolled1 locationNCT07407166
Recruiting
Not Applicable
Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation in Colorectal Cancer Surgery
Gastrointestinal CancerDigestive System Neoplasms
Institute of Oncology Ljubljana60 enrolled1 locationNCT07404527
Recruiting
Not Applicable
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
Breast Cancer
Institute of Oncology Ljubljana130 enrolled1 locationNCT07418125
Recruiting
Phase 2
Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study
Colon Cancer
Institute of Oncology Ljubljana100 enrolled2 locationsNCT06923787
Recruiting
Not Applicable
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
Melanoma and Skin Cancer Trials Limited2,998 enrolled192 locationsNCT03860883
Recruiting
Not Applicable
Biomarkers in Immunotherapy of Melanoma
Metastatic MelanomaImmune Checkpoints InhibitorsGastrointestinal Microbiome (Bacterial and Viral)+1 more
Institute of Oncology Ljubljana150 enrolled1 locationNCT05878977
Recruiting
Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
Breast CancerRadiotherapy Side Effect
Institute of Oncology Ljubljana200 enrolled1 locationNCT06648148
Recruiting
Phase 2Phase 3
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Kartos Therapeutics, Inc.268 enrolled83 locationsNCT05797831
Recruiting
REtroperitoneal SArcoma Registry: an International Prospective Initiative
Retroperitoneal Sarcoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2,000 enrolled22 locationsNCT03838718